It is a form of cancer that originates from breast tissue. When diagnosed and treated early, breast cancer is often curable.
This collaboration will spearhead next-generation sequencing for breast cancer, marking a significant step forward in the fight against this debilitating disease. Reinforcing commitment to Filipino patients, Lotis Ramin, AstraZeneca Country President said, “We are redefining oncology in AstraZeneca, where we aspire for a future where cancer cure is possible through our life-changing medicines, alongside partnerships and ecosystem solutions that allow early detection, diagnosis, and equitable cancer care for patients.”
This approach not only enhances treatment efficacy but also minimizes unnecessary toxicity and side effects, leading to better patient outcomes.